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Summary Oxidative modification of low-density lipoproteins (LDL) contributes to the
pathology of atherosclerosis. Antioxidants may protect LDL against oxidative modification.
Acetaminophen, a widely used analgesic and antipyretic agent, has significant antioxidant
properties. However, there is little evidence to suggest that acetaminophen acts as an antioxidant
for LDL oxidation in vivo. In this study, we investigated the in vivo effect of acetaminophen
on LDL oxidation in hypercholesterolemic rabbits. The oxidative modification of LDL was
identified by conjugated dienes and thiobarbituric acid-reactive substances (TBARS). In the
cholesterol group which rabbits were fed a diet contained 1% g cholesterol for 8 weeks,
TBARS contents and conjugated diene levels in the plasma and isolated LDL samples
significantly increased compared with the control rabbits (p<0.05). However, in the
cholesterol + acetaminophen group, the TBARS contents and conjugated diene levels were
significantly lower than that of the cholesterol group (p<0.05). The results from in vitro studies
also demonstrated that the LDL isolated from serum was oxidized by Cu++ ions and this
oxidation reduced in the presence of acetaminophen. The reduced oxidative modification of
LDL by acetaminophen may be of therapeutic value in preventing the development and
progression of atherosclerosis.
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Introduction
Atherosclerosis and related cardiovascular diseases remain
a major health problem in developed countries. High plasma
total cholesterol and low density lipoproteins (LDL) levels
show significant positive correlation to the development of
atherosclerosis and cardiovascular diseases [1,  2]. It was
reported that the cholesterol content of erythrocytes,
platelets, polymorphonuclear leukocytes and endothelial
cells increased in hypercholesterolemia and this increase
activate these cells and cause the enhanced production of
oxygen free radicals [3, 4].
LDL, the major carrier of blood cholesterol, is thought to
become atherogenic after undergoing oxidative modifications.
It was known that LDL oxidation is accompanied by
alteration in its biological properties, such as endothelial cell
damage, uptake via scavenger receptors in macrophages,
formation of foam cells and fatty streak and increased
amounts of mediators of cell proliferation and platelet
aggregation [1, 2, 5–8].
Many studies have been focused on mechanisms of LDL
oxidation. It was shown that in vitro LDL oxidation can be
induced by transition metal ions, hypochlorite, superoxide/
nitric oxide, organic peroxyl radicals, tocopheryl radicals
and peroxidases, the in vivo mechanisms for LDL oxidative
modification has not yet identified [1, 2, 5–10].
A number of drugs with antioxidant capacity have been
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shown to protect LDL against oxidative modification [11–
13]. Such drugs may have beneficial therapeutic values in the
prevention of atherosclerosis. Acetaminophen, widely used
analgesic and antipyretic drug, is an example which possesses
significant antioxidant effects under certain experimental
conditions [14–17]. However, literature survey has indicated
the paradoxical results for the effect of acetaminophen on
LDL oxidation. Some in vitro studies demonstrated that
oxidative modification of LDL with Cu2+-ions, azo compounds
and peripheral blood mononuclear cells are significantly
reduced by acetaminophen [16,  18], others contrarily
claimed that acetaminophen may also act as a catalyst of
LDL oxidation by myeloperoxidase [19]. Moreover, unique
in vivo data available for the effects of acetaminophen on
LDL oxidation in the literature is an abstract reporting
limited experimental details [20].
Those conflicting results encourage us to investigate the
in vivo effect of acetaminophen on LDL oxidation in hyper-
cholesterolemic rabbits in order to clarify the paradox.
Materials and Methods
Reagents and chemicals
Trisodium citrate anhydrous, 2-thiobarbituric acid, 1,1,3,3-
tetramethoxy propane and bovine serum albumin (BSA)
were obtained from Sigma (St. Louis, MO). Heparin was
obtained from Liquemine 25000 IU/ml, Roche. Paracetamol
(4-hydroxyacetanilide, 4-acetamidophenol) was obtained from
Fluka. Cholesterol (95%) was obtained from ABCR Gmb. &
Co. Cholesterol, high-density lipoprotein (HDL)-cholesterol
and triglyceride enzymatic kits were from Randox Laboratories
Ltd., Antrim, UK. Agarose gels (Titan gel lipoprotein
electrophoresis system) were purchased from Helena
Laboratories, Beaumont, TX USA. Other chemicals used
were of analytical grade.
Animals and diets
Male New Zealand white rabbits weighed from 1.4 to
2 kg (mean ± SD = 1.6 ± 0.16) were studied. They were
housed in individual cages in a room maintained at a
constant temperature and kept on a 12:12 h light-dark cycle.
After a 1-month period of adaptation of the animals, the
experiment was started. Food and water were given daily
and any unused food discarded. The control group (n = 10)
was fed with the standard rabbit diet (Flaran, Izmir, Turkey).
The cholesterol group (n = 10) was fed with standard rabbit
diet containing 1% cholesterol (w/w). The acetaminophen
group (n = 10) were fed with the standard diet containing
1% cholesterol and treated with acetaminophen 200 mg/day
for 8 weeks. The acetaminophen dose (200 mg/daily) is
reported to relevant for analgesic effect to rabbits by oral
route [21]. Acetaminophen solution in water was prepared
daily and was administered to rabbits by gavage.
All animal protocols were approved by the Ege University,
Faculty of Pharmacy Animal Care and Use Committee.
Blood sample collection
For biochemical determinations, blood was taken from
the central ear vein and collected in the test tubes containing
ethylenediaminetetraacetic acid (EDTA) as anticoagulant at
the beginning and at the end of the 8-weeks period. Plasma
was recovered by centrifugation at 4°C, 1500 g for 15 min.
At the end of the study period, 10 ml venous blood from an
ear vein of each animal was drawn into a tube to obtain
serum for LDL isolation.
Preparation of LDL
LDL was isolated by buffered heparin as described in the
literatures [22,  23]. The precipitation buffer consisted of
0.064 M trisodium citrate adjusted to pH 5.05 with 5N HCI,
and contained 50.000 IU/l heparin. Before precipitation of
LDL, serum samples (to which 1 mg/ml of EDTA were
added) and precipitation reagents were allowed to equilibrate
to room temperature. 1 ml of the sample was added to 7 ml
of the heparin-citrate buffer. After mixing with a vortex,
the suspension was allowed to stand for 10 min at room
temperature. The insoluble lipoproteins were then sedimented
by centrifugation at 1000 g for 10 min. The pellet was
resuspended in 1 ml of 0.1 M Na-phosphate buffer, pH 7.4,
containing 0.9% of NaCI. The concentration of LDL protein
was measured by the Lowry method using bovine serum
albumin as standard [24].
Cu++-mediated oxidation of LDL
The isolated LDL from normal human serum was incubated
with 10 µM CuSO4x 5H2O for 6 and 24 hours in 37°C in
the absence and presence of acetaminophen. The oxidation
of LDL was identified by measurement of thiobarbituric
acid reactive substances (TBARS) content and agarose gel
electrophoresis.
Plasma lipids analysis
Plasma total cholesterol (TC), triglyceride (TG) and
HDL-cholesterol were determined enzymatically using a
commercial kit (Randox Lab. Ltd. Crumin, UK). LDL-cho-
lesterol was calculated by Friedewald formula [25].
Identity of oxidized LDL
Oxidation of LDL was identified by measuring two
parameters: the formation of conjugated dienes, the production
of TBARS.
TBARS content was used to represent lipid peroxide
levels and measured by spectrophotometric assay using
1,1,3,3-tetramethoxy propane as a standard, as described by
Yagi and Satoh [26,  27]. The results were expressed as
nmoles of malondialdehyde equivalents.M.B. Özsoy and A. Pabuçcuoğlu
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The conjugated dienes in LDL lipids were determined
directly by measuring the absorbance at 234 nm [22, 28].
Lipids were extracted from LDL samples by chloroform-
methanol (2:1), dried under nitrogen, then redissolved in
cyclohexane, and analyzed spectrophotometrically at 234 nm.
Absorbance units were converted to molar units using the
molar extinction coefficient 2.95 × 104 M−1 cm−1. The results
were expressed as µmol/l to have an estimation of actual
level of oxidized LDL in circulation.
Statistical analysis
All determinations were carried out in duplicate and
median values ± SD were calculated. Differences between
groups were assessed by Kruskal-Wallis and Mann-Witney
non-parametric statistical tests. A difference was considered
significant when p<0.05.
Results
Table 1 shows the plasma levels of TC, TG, HDL-
cholesterol, LDL-cholesterol and TBARS at the beginning
(0 week) and at the end of the experiment (8 weeks). At the
beginning of the experiment, plasma lipid levels of three groups
were similar. However, feeding a cholesterol diet to rabbits
for 8 weeks significantly increased the plasma TC, LDL-
cholesterol and TG levels, in comparison to controls (p<0.05).
No significant differences in rabbit weights were observed
at the end of the study [2.49 ± 0.14 (0 week) − 2.48 ± 0.12
(8 weeks), 2.498 ± 0.08 − 2.451 ± 0.086, 2.5 ± 0.08 − 2.42 ±
0.11 kg for control, cholesterol and cholesterol + acetaminophen
groups, respectively].
As shown in Table 1, the plasma TBARS levels in the
cholesterol group were significantly higher than that of the
controls (p<0.05). However, in the cholesterol + acetaminophen
group, the plasma TBARS levels were significantly lower
than that of the cholesterol group (p<0.05).
Table 2 shows TBARS contents and conjugated diene
levels in isolated LDL samples from experimental groups
serum. The result indicated that TBARS and conjugated
diene levels in isolated LDL from the cholesterol group
were significantly higher than that of the control group
(p<0.05). However, TBARS and conjugated diene levels
in cholesterol + acetaminophen group has lowered when
compared to the cholesterol group levels (Table 2) (p<0.05).
The results from in vitro studies demonstrated that the
LDL samples isolated from normal human serum was
oxidized by Cu++ ions and this oxidation reduced in the
presence of acetaminophen (Table 3).
Table 1. The effect of high cholesterol diet on plasma lipid levels and TBARS content in rabbits
Experimental 
period (week)
Experimental group
Total cholesterol 
(mg/dl)
Triglyceride 
(mg/dl)
HDL-cholesterol 
(mg/dl)
LDL-cholesterol 
(mg/dl)
TBARS 
(nmol/ml)
0 Control 39.73 ± 9.27 77.85 ± 23.98 13.71 ± 2.75 8.85 ± 4.02 0.701 ± 0.05
Cholesterol 42.71 ± 7.14 143.28 ± 30.96 16.26 ± 6.52 10.75 ± 3.05 0.720 ± 0.05
Cholesterol +
Acetaminophen
44.60 ± 8.99 74.24 ± 29.60 14.13 ± 1.60 7.90 ± 1.25 0.740 ± 0.07
8 Control 28.98 ± 14.25 60.35 ± 19.03 7.56 ± 2.57 7.36 ± 5.10 0.725 ± 0.05
Cholesterol 745.89 ± 280.36* 182.35 ± 101.14 9.73 ± 2.54 588.28 ± 219.88* 0.923 ± 0.16*
Cholesterol +
Acetaminophen
534.73 ± 264.25* 57.75 ± 18.82 8.16 ± 3.60 510.25 ± 253.47* 0.717 ± 0.05**
The results are expressed as means ± SD of ten animals per group.
*p<0.05, significant difference to the control group.
**p<0.05, significant difference to the cholesterol group.
Table 2. Conjugated diene levels and TBARS content in LDL isolated from
rabbits serum
Experimental 
groups
TBARS 
(nmol/mg LDL protein)
Conjugated diene levels 
(µM/mg LDL protein)
Control 0.07 ± 0.02 6.40 ± 1.33
Cholesterol 0.15 ± 0.06a 17.26 ± 6.63a
Cholesterol +
Acetaminophen
0.10 ± 0.04a,b 11.61 ± 2.22a,b
The results are expressed as Means ± SD of ten animals per group.
a p<0.05, significant difference to the control group.
b p<0.05, significant difference to the cholesterol group.Oxidized LDL
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Discussion
There is a contradiction about the effect of acetaminophen on
LDL oxidation as prooxidant or antioxidant. It has been shown
that acetaminophen is a potent inhibitor for Cu++-induced
and cell-mediated LDL oxidation in vitro [16]. In addition,
Chou et al. [18] demonstrated that myeloperoxidase(MPO)-
H2O2-nitrite mediated oxidation of LDL was inhibited by
acetaminophen. However, Kapiotis et al. [ 19] found that
acetaminophen increased LDL oxidation by MPO that
generate phenoxyl radical and act as a catalyst of LDL
oxidation in MPO-induced reaction systems. These conflicting
results may be attributed to the different experimental
conditions employed in the studies.
On the other hand, Merrill et al. [14, 15] have reported
that acetaminophen causes an important cardioprotective
effect on isolated heart tissue from experimental animals.
Similarly, Taylor et al. [20] have examined the effect of
acetaminophen on the formation of atherosclerotic plaques
in the cholesterol fed rabbit model and this study was
published as abstract without detailed experimental data.
They reported that formation of atherosclerotic plaques
was significantly decreased at the end of the study and
acetaminophen has capable to inhibit the formation of
oxysterols in LDL.
Those conflicted results encourage us to investigate the in
vivo effect of acetaminophen on LDL oxidation in hyper-
cholesterolemic rabbits.
Table 1 indicates that the cholesterol-supplemented diet
caused marked alterations in the plasma lipoproteins,
particularly an increase of LDL and a decrease of HDL in
comparison with the control group. These findings indicated
that hypercholesterolemia was occurred.
The most widely used methods for monitoring LDL
oxidation are the measurement of conjugated dienes and
TBARS levels [30–33]. Beside the plasma TBARS levels,
conjugated diene levels and TBARS contents in the isolated
LDL samples from the cholesterol group were also significantly
higher than that of the control group (p<0.05) (Table 2). It is
known that high cholesterol diet induce production of oxygen
free radicals leading to lipid peroxidation. The significant
increase of plasma lipid peroxidation in cholesterol-fed
rabbits agrees with previous reports [32, 33].
The addition of acetaminophen to daily diet (200 mg/kg a
day) was clearly reduced TBARS and conjugated diene
levels when compared to the cholesterol group levels (see the
cholesterol + acetaminophen group in Table 2). The reductive
effect of acetaminophen on LDL oxidation may well be
related with its antioxidant capacity which is attributed to
its phenolic structure and are believed to work out via
scavenging free radicals [16, 17, 34, 35].
As a result, our study demonstrate that; (1) after 8 weeks of
feeding 1% g cholesterol diet, rabbits developed significant
elevations of plasma lipid levels; (2) cholesterol-enriched
diet increased in lipid peroxidation; (3) the administration of
200 mg/daily acetaminophen to cholesterol feeding rabbits
reduced lipid peroxidation. On the otherhand, the results
from in vitro studies demonstrated that the LDL samples
isolated from serum was oxidized by Cu++ ions and this
oxidation reduced in the presence of acetaminophen (Table 3).
At this point, a suggestion can be made that acetaminophen
might have a therapeutic value as an alternative drug for
prevention of atherosclerosis which is one of the main
causes of human death in industrialized countries.
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